Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis?
Identifieur interne : 003C23 ( PubMed/Curation ); précédent : 003C22; suivant : 003C24Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis?
Auteurs : James MccarthySource :
- The American journal of tropical medicine and hygiene [ 0002-9637 ] ; 2005.
Descripteurs français
- KwdFr :
- Albendazole (pharmacologie), Albendazole (usage thérapeutique), Animaux, Antihelminthiques (pharmacologie), Antihelminthiques (usage thérapeutique), Association de médicaments, Diéthylcarbamazine (pharmacologie), Diéthylcarbamazine (usage thérapeutique), Filariose lymphatique (), Filariose lymphatique (traitement médicamenteux), Humains, Ivermectine (pharmacologie), Ivermectine (usage thérapeutique), Résistance aux substances (génétique), Tubuline (génétique), Wuchereria bancrofti (), Wuchereria bancrofti (génétique).
- MESH :
- génétique : Résistance aux substances, Tubuline, Wuchereria bancrofti.
- pharmacologie : Albendazole, Antihelminthiques, Diéthylcarbamazine, Ivermectine.
- traitement médicamenteux : Filariose lymphatique.
- usage thérapeutique : Albendazole, Antihelminthiques, Diéthylcarbamazine, Ivermectine.
- Animaux, Association de médicaments, Filariose lymphatique, Humains, Wuchereria bancrofti.
English descriptors
- KwdEn :
- Albendazole (pharmacology), Albendazole (therapeutic use), Animals, Anthelmintics (pharmacology), Anthelmintics (therapeutic use), Diethylcarbamazine (pharmacology), Diethylcarbamazine (therapeutic use), Drug Resistance (genetics), Drug Therapy, Combination, Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (prevention & control), Humans, Ivermectin (pharmacology), Ivermectin (therapeutic use), Tubulin (genetics), Wuchereria bancrofti (drug effects), Wuchereria bancrofti (genetics).
- MESH :
- chemical , genetics : Tubulin.
- chemical , pharmacology : Albendazole, Anthelmintics, Diethylcarbamazine, Ivermectin.
- chemical , therapeutic use : Albendazole, Anthelmintics, Diethylcarbamazine, Ivermectin.
- drug effects : Wuchereria bancrofti.
- drug therapy : Elephantiasis, Filarial.
- genetics : Drug Resistance, Wuchereria bancrofti.
- prevention & control : Elephantiasis, Filarial.
- Animals, Drug Therapy, Combination, Humans.
PubMed: 16103580
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003C23
Links to Exploration step
pubmed:16103580Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis?</title>
<author><name sortKey="Mccarthy, James" sort="Mccarthy, James" uniqKey="Mccarthy J" first="James" last="Mccarthy">James Mccarthy</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:16103580</idno>
<idno type="pmid">16103580</idno>
<idno type="wicri:Area/PubMed/Corpus">003C23</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003C23</idno>
<idno type="wicri:Area/PubMed/Curation">003C23</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003C23</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis?</title>
<author><name sortKey="Mccarthy, James" sort="Mccarthy, James" uniqKey="Mccarthy J" first="James" last="Mccarthy">James Mccarthy</name>
</author>
</analytic>
<series><title level="j">The American journal of tropical medicine and hygiene</title>
<idno type="ISSN">0002-9637</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Albendazole (pharmacology)</term>
<term>Albendazole (therapeutic use)</term>
<term>Animals</term>
<term>Anthelmintics (pharmacology)</term>
<term>Anthelmintics (therapeutic use)</term>
<term>Diethylcarbamazine (pharmacology)</term>
<term>Diethylcarbamazine (therapeutic use)</term>
<term>Drug Resistance (genetics)</term>
<term>Drug Therapy, Combination</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Elephantiasis, Filarial (prevention & control)</term>
<term>Humans</term>
<term>Ivermectin (pharmacology)</term>
<term>Ivermectin (therapeutic use)</term>
<term>Tubulin (genetics)</term>
<term>Wuchereria bancrofti (drug effects)</term>
<term>Wuchereria bancrofti (genetics)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Albendazole (pharmacologie)</term>
<term>Albendazole (usage thérapeutique)</term>
<term>Animaux</term>
<term>Antihelminthiques (pharmacologie)</term>
<term>Antihelminthiques (usage thérapeutique)</term>
<term>Association de médicaments</term>
<term>Diéthylcarbamazine (pharmacologie)</term>
<term>Diéthylcarbamazine (usage thérapeutique)</term>
<term>Filariose lymphatique ()</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Humains</term>
<term>Ivermectine (pharmacologie)</term>
<term>Ivermectine (usage thérapeutique)</term>
<term>Résistance aux substances (génétique)</term>
<term>Tubuline (génétique)</term>
<term>Wuchereria bancrofti ()</term>
<term>Wuchereria bancrofti (génétique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Tubulin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Albendazole</term>
<term>Anthelmintics</term>
<term>Diethylcarbamazine</term>
<term>Ivermectin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Albendazole</term>
<term>Anthelmintics</term>
<term>Diethylcarbamazine</term>
<term>Ivermectin</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Drug Resistance</term>
<term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Résistance aux substances</term>
<term>Tubuline</term>
<term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Albendazole</term>
<term>Antihelminthiques</term>
<term>Diéthylcarbamazine</term>
<term>Ivermectine</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Albendazole</term>
<term>Antihelminthiques</term>
<term>Diéthylcarbamazine</term>
<term>Ivermectine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Drug Therapy, Combination</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Association de médicaments</term>
<term>Filariose lymphatique</term>
<term>Humains</term>
<term>Wuchereria bancrofti</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16103580</PMID>
<DateCreated><Year>2005</Year>
<Month>08</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted><Year>2005</Year>
<Month>10</Month>
<Day>11</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0002-9637</ISSN>
<JournalIssue CitedMedium="Print"><Volume>73</Volume>
<Issue>2</Issue>
<PubDate><Year>2005</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of tropical medicine and hygiene</Title>
<ISOAbbreviation>Am. J. Trop. Med. Hyg.</ISOAbbreviation>
</Journal>
<ArticleTitle>Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis?</ArticleTitle>
<Pagination><MedlinePgn>232-3</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McCarthy</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Am J Trop Med Hyg</MedlineTA>
<NlmUniqueID>0370507</NlmUniqueID>
<ISSNLinking>0002-9637</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000871">Anthelmintics</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014404">Tubulin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>70288-86-7</RegistryNumber>
<NameOfSubstance UI="D007559">Ivermectin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>F4216019LN</RegistryNumber>
<NameOfSubstance UI="D015766">Albendazole</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber>
<NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D015766" MajorTopicYN="N">Albendazole</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000871" MajorTopicYN="N">Anthelmintics</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004351" MajorTopicYN="Y">Drug Resistance</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007559" MajorTopicYN="N">Ivermectin</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014404" MajorTopicYN="N">Tubulin</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014958" MajorTopicYN="N">Wuchereria bancrofti</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year>
<Month>8</Month>
<Day>17</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2005</Year>
<Month>10</Month>
<Day>12</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2005</Year>
<Month>8</Month>
<Day>17</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">16103580</ArticleId>
<ArticleId IdType="pii">73/2/232</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003C23 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003C23 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:16103580 |texte= Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis? }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:16103580" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |